06/25/2026
"Demand for temperature-sensitive biologics is projected to expand at an 8.3% compound annual growth rate through 2033, reaching an estimated $39.1 billion, according to Growth Market Reports. Temperature deviations from defined parameters are a major concern for drug makers, with cold-chain failures costing up to $35 billion per year and contributing up to 50% of global vaccine waste, the World Health Organization estimates." · FreightWaves
UPS has invested $48 million in chilled trucking facilities optimized for speed and short-term storage.